Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Beauty Health ( (SKIN) ).
On June 12, 2025, The Beauty Health Company held its annual stockholders meeting virtually, where 78.40% of the shares were represented, establishing a quorum. During the meeting, seven directors were elected for a one-year term, Deloitte & Touche LLP was ratified as the independent auditor, and the compensation for named executive officers was approved on a non-binding basis.
The most recent analyst rating on (SKIN) stock is a Hold with a $1.20 price target. To see the full list of analyst forecasts on Beauty Health stock, see the SKIN Stock Forecast page.
Spark’s Take on SKIN Stock
According to Spark, TipRanks’ AI Analyst, SKIN is a Neutral.
Beauty Health’s overall score is primarily impacted by its financial challenges, with high leverage and negative profit margins being key concerns. However, positive elements such as improved cash flow, recent refinancing efforts, and strong consumable sales support a more favorable outlook. Technical indicators provide mixed signals, while the earnings call highlights both achievements and ongoing hurdles.
To see Spark’s full report on SKIN stock, click here.
More about Beauty Health
The Beauty Health Company operates in the beauty and health industry, focusing on providing beauty products and services. The company is known for its innovative solutions and market presence in the beauty sector.
Average Trading Volume: 794,765
Technical Sentiment Signal: Sell
Current Market Cap: $194.1M
Find detailed analytics on SKIN stock on TipRanks’ Stock Analysis page.